Eurofins Scientific is an international life sciences company providing a unique range of analytical testing services to clients across multiple industries to make life and our environment safer, healthier, and more sustainable. From the food you eat and the water you drink to the medicines you rely on, Eurofins works with some of the world’s largest companies to ensure product safety, authenticity, and regulatory compliance.
In just over 30 years, Eurofins has grown from a single laboratory in Nantes, France, to more than 47,000 employees across over 900 independent companies in more than 50 countries, operating over 800 laboratories worldwide. Eurofins offers a portfolio of more than 200,000 analytical methods and is a global leader in food, environmental, pharmaceutical, cosmetics, and agroscience CRO services, as well as genomics, discovery pharmacology, forensics, CDMO, and clinical study support.
Eurofins Professional Scientific Services (PSS) is seeking an In Vitro Toxicology Research Associate to support the prioritization and de‑risking of novel therapeutic agents throughout the drug discovery and development process. This role focuses on the design, execution, and interpretation of human and preclinical in vitro safety models
The Research Associate will work onsite at a client location and collaborate closely with cross‑functional stakeholders, including toxicology, medicinal chemistry, DMPK, and research teams. The anticipated start date for this position is July 2026
Key Responsibilities
Knowledge and Skills
Education and Experience
What to Expect in the Hiring Process:
Additional Details:
This is a full‑time, onsite role operating on a first‑shift schedule (Monday through Friday, 8:00 AM to 5:00 PM). Overtime is required as needed, with occasional weekend work. Candidates located within a commutable distance to Boston, MA, are strongly encouraged to apply.
Excellent full-time benefits include:
Eurofins USA PSS Insourcing Solutions is a Disabled and Veteran Equal Employment Opportunity employer.

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories.
Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing.
Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.